Viva Pharma Pvt Ltd - Due diligence report

A 360° intelligence report on Viva Pharma Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and distress si…

1988-04-20 Jorhat, Assam Strike Off Unlisted Active Compliant
Share
Connect MCP
VP Viva Pharma Pvt Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Viva Pharma Pvt Ltd — 360° Intelligence Report

Generated from MCA filings & public records
48/100
Trust Score
Caution Indicated

Viva Pharma Pvt Ltd is assessed as Caution Indicated with a Trust Score of 48/100. Viva Pharma Pvt Ltd is a private limited indian non-government company incorporated in 1988, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 08 Aug 2026 from the latest processed filings. Viva Pharma Pvt Ltd snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
48/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
16/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
35/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 4 satisfied (2.21 cr).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India1 48.0 cr
United Bank Of India1 48.0 cr
Assam Financial Corporation1 48.0 cr
Icici Bank Limited1 48.0 cr
Compliance Score: 16/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Last balance sheet is for Mar 2021 - filings overdue.
  • Litigation present in 2 court forum(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
PARTHA SARATHI SAIKIA 01234567 Director 01/04/2018 6 yrs Approved
DEEPIKA SAIKIA 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: PARTHA SARATHI SAIKIA (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 35
Growth signals & trust indicators
Profit expanded 38% year-on-year.
Operating for 38+ years.
Distress signals & risk flags
Negative net worth.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (16/100).
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence31/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment41/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view46/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 14 events
30 Nov 2021
Last AGM held
Annual general meeting
31 Mar 2021
Latest balance sheet
Filed with ROC
28 May 2020
Charge satisfied
Icici Bank Limited
07 Aug 2018
Director ceased
SATYA SARATHI SAIKIA
17 Dec 2015
Charge satisfied
United Bank Of India
08 Oct 2015
Charge created
Icici Bank Limited - 40.00 Lakh
02 Jul 2013
Charge satisfied
State Bank Of India
24 Jun 2013
Charge created
United Bank Of India - 58.75 Lakh
14 Aug 2009
Charge created
State Bank Of India - 76.00 Lakh
18 Sep 2008
Charge satisfied
Assam Financial Corporation
08 Nov 1991
Charge created
Assam Financial Corporation - 46.00 Lakh
20 Oct 1990
Director appointed
DEEPIKA SAIKIA (Director)
20 Apr 1988
Incorporated
Registered with Roc Guwahati
Director appointed
PARTHA SARATHI SAIKIA (Managing Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
2 active director(s) / partner(s); board looks stable and experienced.
All 4 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Medwock Pharmaceuticals Private Limited U24110DL2019PTC348789 Pitampura, Delhi, India
Redmey Pharmaceutical Private Limited U51909BR2018PTC038061 Muzaffarpur, Bihar, India
Medigift Pharmaceuticals Private Limited U51909WB2016PTC217634 Kolkata, West Bengal, India
Rgeno Pharmaceuticals Private Limited U74999MH2018PTC304439 Navi Mumbai, Maharashtra, India
Rosenwell Health Care Private Limited U74999DL2018PTC335946 New Delhi, Delhi, India
Dorex Pharmaceuticals (India) Private Limited U24231HR1983PTC015949 Gurgaon, Haryana, India
Saket Biotech Private Limited U24230MH2004PTC150306 Nagpur, Maharashtra, India
Suncare Laboratories Private Limited U24100WB2014PTC204313 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Viva Pharma Pvt Ltd before audits and certifications: compliance score 16/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Viva Pharma Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Viva Pharma Pvt Ltd - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 48/100, distress signals and MSME payment-delay disclosures - know whether Viva Pharma Pvt Ltd pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Viva Pharma Pvt Ltd - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Viva Pharma Pvt Ltd an active company?

Viva Pharma Pvt Ltd has MCA status “Strike Off” with a compliance score of 16/100 (Caution Indicated).

Is Viva Pharma Pvt Ltd financially healthy?

Viva Pharma Pvt Ltd has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Viva Pharma Pvt Ltd?

Its overall Trust Score is 48/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Viva Pharma Pvt Ltd?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Viva Pharma Pvt Ltd have loans or charges against its assets?

No open charges - all 4 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Viva Pharma Pvt Ltd up to date with its ROC filings?

Last balance sheet is for Mar 2021 - filings overdue. Overall compliance score: 16/100 (Caution Indicated).

Is it risky to lend to Viva Pharma Pvt Ltd?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.